ANTIPLATELET EFFECTS OF R,S-(MESO)-ALPHA, '-BIS[3-(N,N-DIETHYLCARBAMOYL)PIPERIDINO]-P-XYLENE EX-VIVO IN THE DOG AND IN-VIVO IN THE MOUSE

Citation
Gz. Han et al., ANTIPLATELET EFFECTS OF R,S-(MESO)-ALPHA, '-BIS[3-(N,N-DIETHYLCARBAMOYL)PIPERIDINO]-P-XYLENE EX-VIVO IN THE DOG AND IN-VIVO IN THE MOUSE, General pharmacology, 28(4), 1997, pp. 617-621
Citations number
16
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
ISSN journal
03063623
Volume
28
Issue
4
Year of publication
1997
Pages
617 - 621
Database
ISI
SICI code
0306-3623(1997)28:4<617:AEOR'>2.0.ZU;2-C
Abstract
1. The nipecotamide '-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene (A-1) is a platelet aggregation inhibitor. The meso diastereomer A-1c is superior in potency and duration to the synthetic diastereomeric m ixture consisting of the R,R-, S,S-, and R,S- (meso) isomers in inhibi ting collagen-induced platelet aggregation ex vivo in the dog. 2. A-1c also is more potent and longer acting than A-1 in protecting mice fro m collagen+epinephrine-induced thromboembolic death. 3. The mechanism of antiplatelet action of this compound appears to be related to its a bility to prevent agonist-induced inhibition of platelet cyclic adenos ine monophosphate (cAMP) levels. (C) 1997 Elsevier Science Inc.